Related references
Note: Only part of the references are listed.Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation
Taiji Tsunemi et al.
HUMAN MOLECULAR GENETICS (2014)
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes
Stephanie M. Y. Kong et al.
HUMAN MOLECULAR GENETICS (2014)
Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction
Jin-Sung Park et al.
HUMAN MOLECULAR GENETICS (2014)
Identification of p.Gln858*in ATP13A2 in two EOPD patients and presentation of their clinical features
Maryam Malakouti-Nejad et al.
NEUROSCIENCE LETTERS (2014)
ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons
Hideaki Matsui et al.
FEBS LETTERS (2013)
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited -synuclein accumulation and age-dependent sensorimotor deficits
Patrick J. Schultheis et al.
HUMAN MOLECULAR GENETICS (2013)
The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease
Anne Y. Y. Chan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Lysosomal impairment in Parkinson's disease
Benjamin Dehay et al.
MOVEMENT DISORDERS (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Mitochondrial Inhibitor Models of Huntington's Disease and Parkinson's Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo
Christian T. Sheline et al.
NEURODEGENERATIVE DISEASES (2013)
Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients
Hossein Darvish et al.
NEUROSCIENCE LETTERS (2013)
Genetics of Parkinson's disease – state of the art, 2013
Vincenzo Bonifati
PARKINSONISM & RELATED DISORDERS (2013)
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
Karen E. Murphy et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9)
H. Eiberg et al.
CLINICAL GENETICS (2012)
CLN5 and CLN8 protein association with ceramide synthase: Biochemical and proteomic approaches
Saria El Haddad et al.
ELECTROPHORESIS (2012)
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
David Ramonet et al.
HUMAN MOLECULAR GENETICS (2012)
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
Jose Bras et al.
HUMAN MOLECULAR GENETICS (2012)
Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity
Marija Usenovic et al.
JOURNAL OF NEUROSCIENCE (2012)
Lysosome-dependent pathways as a unifying theme in Parkinson's disease
George K. Tofaris
MOVEMENT DISORDERS (2012)
ATP13A2 regulates mitochondrial bioenergetics through macroautophagy
Aaron M. Gusdon et al.
NEUROBIOLOGY OF DISEASE (2012)
ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
Gerda Rentschler et al.
NEUROTOXICOLOGY (2012)
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
Benjamin Dehay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Genetics and Epigenetics of Parkinson's Disease
Fabio Coppede
SCIENTIFIC WORLD JOURNAL (2012)
Lack of association between three single nucleotide polymorphisms in the PARK9, PARK15, and BST1 genes and Parkinson's disease in the northern Han Chinese population
Zhu Lan-hui et al.
CHINESE MEDICAL JOURNAL (2012)
ATP13A2 Variability in Taiwanese Parkinson's Disease
Chiung-Mei Chen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation
Choong Yi Fong et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2011)
Pathogenic Effects of Novel Mutations in the P-Type ATPase ATP13A2 (PARK9) Causing Kufor-Rakeb Syndrome, a Form of Early-Onset Parkinsonism
Jin-Sung Park et al.
HUMAN MUTATION (2011)
Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein
Jieqiong Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
PLA2G6 variant in Parkinson's disease
Hiroyuki Tomiyama et al.
JOURNAL OF HUMAN GENETICS (2011)
Patterns of levels of biological metals in CSF differ among neurodegenerative diseases
Isao Hozumi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Fighting neurodegeneration with rapamycin: mechanistic insights
Jordi Bove et al.
NATURE REVIEWS NEUROSCIENCE (2011)
A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers
Fabiana H. G. Farias et al.
NEUROBIOLOGY OF DISEASE (2011)
Serum Vitamins and Heavy Metals in Blood and Urine, and the Correlations among Them in Parkinson's Disease Patients in China
Tetsuhito Fukushima et al.
NEUROEPIDEMIOLOGY (2011)
Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability
Lucio Santoro et al.
NEUROGENETICS (2011)
Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation
David Crosiers et al.
PARKINSONISM & RELATED DISORDERS (2011)
A One Base Pair Deletion in the Canine ATP13A2 Gene Causes Exon Skipping and Late-Onset Neuronal Ceroid Lipofuscinosis in the Tibetan Terrier
Anne Woehlke et al.
PLOS GENETICS (2011)
Manganese and Parkinson's Disease: A Critical Review and New Findings
Tomas R. Guilarte
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Rapid Screening of ATP13A2 Variant with High-Resolution Melting Analysis
Manabu Funayama et al.
MOVEMENT DISORDERS (2010)
Clinical Spectrum of Kufor-Rakeb Syndrome in the Chilean Kindred with ATP13A2 Mutations
Maria I. Behrens et al.
MOVEMENT DISORDERS (2010)
ATP13A2 Mutations (PARK9) Cause Neurodegeneration with Brain Iron Accumulation
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2010)
The emerging role of iron dyshomeostasis in the mitochondrial decay of aging
Jinze Xu et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation
Maura Poli et al.
NEUROBIOLOGY OF DISEASE (2010)
Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China
Qing-Zhou Fei et al.
NEUROSCIENCE LETTERS (2010)
ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from mainland China
X-Y. Mao et al.
PARKINSONISM & RELATED DISORDERS (2010)
Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2
Karyn Schmidt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2009)
ATP13A2 Variability in Parkinson Disease
Carles Vilarino-Guell et al.
HUMAN MUTATION (2009)
Genetic Association Study of the P-Type ATPase ATP13A2 in Late-Onset Parkinson's Disease
Aleksandar Rakovic et al.
MOVEMENT DISORDERS (2009)
ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls
Ana Djarmati et al.
MOVEMENT DISORDERS (2009)
α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
Aaron D. Gitler et al.
NATURE GENETICS (2009)
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
Pier Giorgio Mastroberardino et al.
NEUROBIOLOGY OF DISEASE (2009)
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
A. Di Fonzo et al.
NEUROLOGY (2009)
Neurodegenerative lysosomal disorders - A continuum from development to late age
Ralph A. Nixon et al.
AUTOPHAGY (2008)
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
Jose Bras et al.
FEBS JOURNAL (2008)
Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore
C. H. Lin et al.
NEUROLOGY (2008)
PARK9-linked parkinsonism in eastern Asia:: Mutation detection in ATP13A2 and clinical phenotype
Y. P. Ning et al.
NEUROLOGY (2008)
C-elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging
Tjakko J. van Ham et al.
PLOS GENETICS (2008)
Integral and associated lysosomal membrane proteins
Bernd Schroeder et al.
TRAFFIC (2007)
Individual dopaminergic neurons show raised iron levels in Parkinson disease
A. E. Oakley et al.
NEUROLOGY (2007)
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
A. Di Fonzo et al.
NEUROLOGY (2007)
Neuronal ceroid lipofuscinosis: A common pathway?
Dixie-Ann Persaud-Sawin et al.
PEDIATRIC RESEARCH (2007)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
Increased incidence of Parkinson disease among relatives of patients with Gaucher disease
Assaf Halperin et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Iron metabolism in parkinsonian syndromes
Daniela Berg et al.
MOVEMENT DISORDERS (2006)
Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia
DR Williams et al.
MOVEMENT DISORDERS (2005)
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
Y Li et al.
NEUROLOGY (2005)
Characterization of the P5 subfamily of P-type transport ATPases in mice
PJ Schultheis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama
JG Burneo et al.
EPILEPSIA (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunction
PCG Nijssen et al.
MOVEMENT DISORDERS (2002)
Share Paper
